Redbud Labs, Inc. — Department of Health and Human Services SBIR Phase I: NIAID

Description

of Hospital acquired infection that leads to sepsis is deadly expensive and increasingly common Rapid diagnosis anti microbial treatment and identification of the pathogen strain is key to improving outcomes and reducing costs Diagnosis and strain identification must improve Novel techniques for blood culture BC and molecular diagnostics MDx are promising but better technology for pathogen purification and concentration from blood will be essential for the next generation of diagnostics We will develop a device to purify and concentrate pathogens directly from a large volume mL of whole blood Unlike existing techniques our technology will achieve the high binding efficiency of a filter with the non clogging properties of an empty flow cell of A device to purify and concentrate pathogens directly from a large volume of whole blood will be developed with the goal of improving improve blood culture and molecular diagnostics